Skip to main content

Guidewire Software, Inc.

For the period ended Jul 31, 2025. Filed Sep 11, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Sep 11, 2025

GWRE$160.84-0.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Operations

(in thousands, except share and per share amounts)

Fiscal years ended July 31,
202520242023
Revenue:
Subscription and support$731,296$549,087$429,667
License251,935250,176265,593
Services219,228181,234210,081
Total revenue1,202,459980,497905,341
Cost of revenue:
Subscription and support235,106204,794210,507
License3,6244,5366,488
Services211,676187,806230,135
Total cost of revenue450,406397,136447,130
Gross profit:
Subscription and support496,190344,293219,160
License248,311245,640259,105
Services7,552(6,572)(20,054)
Total gross profit752,053583,361458,211
Operating expenses:
Research and development296,160269,381249,746
Sales and marketing230,346199,033188,224
General and administrative184,479167,520169,731
Total operating expenses710,985635,934607,701
Income (loss) from operations41,068(52,573)(149,490)
Interest income56,62543,47824,389
Interest expense(13,211)(6,738)(6,716)
Other income (expense), net(35,087)(11,005)(2,277)
Income (loss) before provision for (benefit from) income taxes49,395(26,838)(134,094)
Provision for (benefit from) income taxes(20,409)(20,735)(22,239)
Net income (loss)$69,804$(6,103)$(111,855)
Net income (loss) per share:
Basic$0.83$(0.07)$(1.36)
Diluted$0.81$(0.07)$(1.36)
Shares used in computing net income (loss) per share:
Basic83,846,79382,291,48382,176,629
Diluted85,911,65382,291,48382,176,629
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.